Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Antiseizure Medication in Seizure Networks at Early Stages of Acute Brain Injury. The Rs-fMRI, Open-label Pilot Trial

NCT06081283 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT06081283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06081283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Antiseizure Medication in Seizure Networks at Early Stages of Acute Brain Injury. The Rs-fMRI, Open-label Pilot Trial
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Phase 4
Overall status
Terminated
Start date
November 20, 2023
Completion date
January 22, 2025
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain hypoxia, brain injuries, acute, brain injuries, traumatic, brain ischemia, coma, heart arrest, hypoxia-ischemia, brain, intracranial hemorrhages, persistent vegetative state, stroke